1. Home
  2. BNTC vs AIRS Comparison

BNTC vs AIRS Comparison

Compare BNTC & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.99

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$2.27

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
AIRS
Founded
1995
2012
Country
United States
United States
Employees
24
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.3M
328.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BNTC
AIRS
Price
$10.99
$2.27
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$27.67
N/A
AVG Volume (30 Days)
118.5K
806.6K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
6.67
N/A
EPS
N/A
N/A
Revenue
N/A
$151,818,000.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$5.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$1.51
52 Week High
$16.76
$12.00

Technical Indicators

Market Signals
Indicator
BNTC
AIRS
Relative Strength Index (RSI) 36.33 35.44
Support Level $10.04 $1.85
Resistance Level $14.14 $3.31
Average True Range (ATR) 0.65 0.17
MACD -0.17 0.03
Stochastic Oscillator 9.25 20.23

Price Performance

Historical Comparison
BNTC
AIRS

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: